[
  {
    "ts": "2026-01-08T02:18:03+00:00",
    "headline": "Revolution Medicines (RVMD) Hits All-Time High on Buyout Buzz; Buyer Denies Talks",
    "summary": "We recently published 10 Stocks With Massive Gains; 5 at Record Highs. Revolution Medicines, Inc. (NASDAQ:RVMD) was one of the top performers on Wednesday. Revolution Medicines soared to a new all-time high on Wednesday, as investors took path from a report from The Wall Street Journal that it was set to be acquired by AbbVie […]",
    "url": "https://finance.yahoo.com/news/revolution-medicines-rvmd-hits-time-021803051.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "d41f9ce8-a0b1-359c-8449-1416338d888a",
      "content": {
        "id": "d41f9ce8-a0b1-359c-8449-1416338d888a",
        "contentType": "STORY",
        "title": "Revolution Medicines (RVMD) Hits All-Time High on Buyout Buzz; Buyer Denies Talks",
        "description": "",
        "summary": "We recently published 10 Stocks With Massive Gains; 5 at Record Highs. Revolution Medicines, Inc. (NASDAQ:RVMD) was one of the top performers on Wednesday. Revolution Medicines soared to a new all-time high on Wednesday, as investors took path from a report from The Wall Street Journal that it was set to be acquired by AbbVie […]",
        "pubDate": "2026-01-08T02:18:03Z",
        "displayTime": "2026-01-08T02:18:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/d13bc0eacb984711f97f75d4d5fa774a",
          "originalWidth": 768,
          "originalHeight": 474,
          "caption": "I'll Play, Says Jim Cramer About Bristol-Myers (BMY)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mwG_K7ERKsXp5c8CgY3M_w--~B/aD00NzQ7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/d13bc0eacb984711f97f75d4d5fa774a.cf.webp",
              "width": 768,
              "height": 474,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qq.4GqsrpbstuiBHkHyOXg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/d13bc0eacb984711f97f75d4d5fa774a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/revolution-medicines-rvmd-hits-time-021803051.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/revolution-medicines-rvmd-hits-time-021803051.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RVMD"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]